Skip Navigation
Search Menu
News and Publications

In This Section      
Print This Page

Current News Releases

Current News Releases

Released: January 24, 2017

The Johns Hopkins Wilmer Eye Institute will provide free eye screenings for Baltimore seniors as part of its Screening to Prevent Glaucoma (SToP Glaucoma) program. It will be held during an event at the Mary Harvin Senior Center on Thursday, Jan. 26. The free screening events is aimed at eliminating some of the barriers to accessing healthcare faced by Baltimore residents.

Released: January 23, 2017

Ultrasound pulses activate release of drugs from nanoparticles

Biomedical engineers at Johns Hopkins report they have worked out a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound. The method first “cages” a drug inside tiny, biodegradable “nanoparticles,” then activates its release through precisely targeted sound waves, such as those used to painlessly and noninvasively create images of internal organs.

Released: January 18, 2017

Daniel O’Connor, Ph.D., an assistant professor of neuroscience at the Johns Hopkins University School of Medicine, is among 102 winners of Presidential Early Career Awards for Scientists and Engineers, which were announced by the White House on Jan. 9. The awards are the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers.

Released: January 17, 2017

Albert H. Owens Jr., M.D., a Johns Hopkins oncologist who played a leadership role in developing oncology as a scientific discipline and clinical specialty — and who also served as president of The Johns Hopkins Hospital — died Jan. 13 at the age of 90.

Released: January 17, 2017

Coronary artery calcium score gives risk assessment to prevent over- or undertreatment of blood pressure

Using data from a national study, Johns Hopkins researchers determined that using heart CT scans can help personalize treatment in patients whose blood pressure falls in the gray zone of just above normal or mild high blood pressure. Previously, the appropriate blood pressure treatment for these patients used risk calculations and some guesswork, potentially leaving many vulnerable to heart disease or taking drugs they don’t need. Nearly one in three adults in the U.S. has prehypertension, blood pressure higher than normal but not considered high yet.

Released: January 16, 2017

Epigenetic changes, not DNA mutations, drive some metastasis

A multicenter team of researchers reports that a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer suggests that chemical changes to DNA that do not affect the DNA sequence itself yet control how it operates confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply.

Released: January 12, 2017

Study shows how and why hairlike structures on cells are lost

Many of our cells are equipped with a hairlike “antenna” that relays information about the external environment to the cell, and scientists have already discovered that the appearance and disappearance of these so-called primary cilia are synchronized with the process of cellular duplication, called mitosis. Now, cell biologists at Johns Hopkins report the discovery of new information about how this “hair loss” and cell duplication are linked through the dramatic clipping of the tips of the cilia — what the scientists dub decapitation — that begins their disassembly.

Released: January 12, 2017

Young scientists interested in bladder cancer research can compete for up to two awards totaling $100,000 from a joint effort between the Johns Hopkins Greenberg Bladder Cancer Institute and the Bladder Cancer Advocacy Network (BCAN).

Released: January 11, 2017

New heart disease “staging” system focuses on those previously considered at low risk

Experts at Johns Hopkins and New York’s Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.

Released: January 10, 2017

Insight into cellular mechanisms illuminates biological target for PTSD therapy

Experiments in mice by researchers at Johns Hopkins suggest that if the goal is to ease or extinguish fearful emotional memories like those associated with post-traumatic stress disorder, alcohol may make things worse, not better. Results of their study demonstrate, they say, that alcohol strengthens emotional memories associated with fearful experiences and prevents mice from pushing aside their fears.

Released: January 9, 2017

Johns Hopkins researchers who conducted a dozen focus groups with 70 straight and gay/bisexual Hispanic and African-American males ages 15 to 24 report that gaining a better understanding of the context in which young men grow up will allow health care providers to improve this population’s use of sexual and reproductive health care.

Released: January 9, 2017

Johns Hopkins researchers along with academic and drug industry investigators say they have identified a new biological target for treating spinal muscular atrophy. They report they have evidence that an experimental medicine aimed at this target works as a “booster” in conjunction with a drug called nusinersen that was recently FDA-approved to improve symptoms of the disorder in mice.

Released: January 5, 2017

Johns Hopkins Medicine today announced a collaborative agreement with Under Armour Inc. that introduces evidence-based science along with expert insights to the Under Armour Connected Fitness™ platform, which includes a suite of health and fitness applications: UA Record™, MapMyFitness®, MyFitnessPal® and Endomondo™.

Released: January 5, 2017

Robert Wood, M.D., director of pediatric allergy and immunology and professor of pediatrics at the Johns Hopkins University School of Medicine, is available to discuss the National Institute of Allergy and Infectious Diseases' new Guidelines for the Prevention of Peanut Allergy and their implications.

Released: January 5, 2017

Discovery could explain widespread acquired resistance among patients treated with immune checkpoint blockade drugs

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells. The study, conducted by researchers on the cells of five of their patients treated at the Johns Hopkins Kimmel Cancer Center, is described online Dec. 28 in Cancer Discovery.

Released: January 4, 2017

Inez Stewart, M.Ed., has assumed the role of senior vice president of human resources for the Johns Hopkins Health System.

Released: January 3, 2017

The Department of Physical Medicine and Rehabilitation at Johns Hopkins Medicine is expanding to continue improving the quality of patient care. New facilities are needed not only to address a growing demand for health care but also to advance the standard of compassionate, individualized care at Johns Hopkins Medicine.

Released: December 30, 2016

Survey assesses both risky behaviors and positive outcomes

In a survey of almost 2,000 people who said they had had a past negative experience when taking psilocybin-containing “magic mushrooms,” Johns Hopkins researchers say that more than 10 percent believed their worst “bad trip” had put themselves or others in harm’s way, and a substantial majority called their most distressing episode one of the top 10 biggest challenges of their lives

Released: December 23, 2016

Four-year "J-CHiP" study helps hospitals operate more efficiently while helping patients in their homes

When people with chronic health problems couldn't get around town to their doctors' appointments, a four-year Johns Hopkins program brought the appointments to them.

Released: December 22, 2016

2016 winners announced across the health system

Johns Hopkins Medicine hosted its second annual awards program, the Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams, honoring 42 physicians and care teams who embody the best in clinical excellence. The program was launched by the Office of Johns Hopkins Physicians, and awards were open to providers who practice within Johns Hopkins Medicine, including Johns Hopkins Community Physicians locations.